Related Blog Posts
First Ever Clinical Study Shows Dental Stem Cells Regrow Bone - Dental Health Magazine
3 hours ago ago from WorlDental.org - Dental Health Magazine. Free Dentistry Information and Dental News for Patients
NEW YORK – In a statement today, StemSave (TM), Inc., the market leader in the field of stem cell recovery and cryo-preservation lauds research published in the November issue of the European Cells and Materials Journal citing the reconstruction of the human mandible bone with autologous dental pulp stem cells. StemSave commends Italian researchers from the 2nd University of Naples for their groundbreaking work. This marks the first time ...
Related contentNEWS SHORTS FOR TUESDAY
11 hours ago ago from DATAMINDER 3.0
NEWS SHORTS FOR TUESDAY ( Referral to Web sites not produced by The Illinois Federation for Right to LIfe is for informational purposes only and does not necessarily constitute an endorsement of the sites' content. ) Hearing On Challenge To Okla. Abortion Law Delayed After Change Of Judges Oklahoma County District Judge Twyla Mason Gray has recused herself from a lawsuit challenging an Oklahoma law that would require women seeking ...
Related contentStudy Finds No Cancer Link To Cell-Phone Usage | Mobile Technology …
19 hours ago ago from Cell Wireless Phone
A large new study is the latest to find no link between rising cell phone use and rates of brain cancer. Researchers in four Scandinavian countries found no increase in brain tumor diagnoses from 1998 to 2003, when cell phone use in See more here:Â Study Finds No Cancer Link To Cell-Phone Usage | Mobile Technology
Related contentCleveland Clinic receives $2.75M grant to study stem cell use in treating MS
14 hours ago ago from ** Stu's Views & M.S. News **
By SHANNON MORTLAND 11:38 am, December 8, 2009 The Cleveland Clinic has received a $2.75 million federal grant to study the use of stem cells in treating multiple sclerosis. The four-year grant from the Department of Defense will fund a 24-patient study to be done by the Center for Stem Cell and Regenerative Medicine, which is made up of investigators from biotech company Athersys Inc., Case Western Reserve University, the ...
Related contentResearchers Turn Stem Cells Into Genetic Vaccine For HIV
21 hours ago ago from Scientific Blogging - The world's best scientists. The internet's smartest readers. Science 2.0
Track your comments! [x] When you register, comments on your articles and replies to your comments appear here. Register Now ! Sign in to your account [x] Not a Scientific Blogging member yet? Register Now for a Free Scientificblogging.com Account Customize your profile with pictures, banner, a blogroll and more. Leave comments on articles, add other members to your friend lists, chat with people ...
Related contentRelated News
First Ever Clinical Study Shows Dental Stem Cells Regrow Bone
12 hours ago ago from FanHouse
In a statement today, StemSave (TM), Inc., the market leader in the field of stem cell recovery and cryo-preservation lauds research published in the November issue of the European Cells and Materials Journal citing the reconstruction of the human mandible bone with autologous dental pulp stem cells. StemSave commends Italian researchers from the 2 nd University of Naples for their groundbreaking work. This marks the first time dental stem ...
Related contentMillipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project
16 hours ago ago from FanHouse
ST. JOSEPH, Mich., Dec. 8 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as ...
Related contentDr. Sherri Tenpenny: Novartis Is Celebrating. Should We?
5 hours ago ago from Huffington Post
On November 24, 2009, Novartis officially opened its first, large-scale vaccine manufacturing facility in the U.S. Located in Holly Springs, North Carolina. The project is a collaborative effort between Novartis and the U.S. Department of Health and Human Services, which contributed $457M for the design, construction, and licensing of the facility. For its part in the deal, Novartis is required to provide two commercial-scale lots of ...
Related contentCytheris Announces Initiation of CONVERT, a Phase I/IIa Study of Recombinant Human Interleukin-7 (CYT107) in Combination with Antiviral Therapy and Vaccination for Treatment of Chronic Hepatitis B Virus
17 hours ago ago from PopEater
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) ...
Related contentGenzyme’s Mozobil Shows Promise in Chemosensitization
14 hours ago ago from FanHouse
Genzyme Corporation (Nasdaq: GENZ) announced today that a Phase 1/2 trial provided early clinical data suggesting that Mozobil® (plerixafor injection) in combination with chemotherapy may offer a therapeutic impact on leukemic cells protected in bone marrow. The investigational trial, partially supported by Genzyme, was the subject of an oral presentation at the 2009 annual meeting of the American Society of Hematology in New Orleans, LA. ...
Related contentRelated Videos
Nothing to see... move along.
